Physicians using gene expression classifier testing said that in 86% of cases, identifying a benign result through testing and potentially avoiding surgery improved patient safety.
Second primary malignancies among patients with post-Chernobyl papillary thyroid cancer include hematological malignancies, breast carcinoma, cervical carcinoma, and colon carcinomas.
Thyroid function improved after the researchers placed the child on levothyroxine and supplemented his diet with iodized salt and a multivitamin containing iodine.
Genetic alterations were found in both cancerous and benign samples.
Patients had reduced left middle hippocampus and right anterior hippocampus activity when judging word pairs.
Results in this expanded series reaffirm the data in the pilot study and show a 5-year overall survival rate of 43%.
Patients with medullary thyroid cancer taking cabonzantinib lived more than 2 years longer if their tumors had a RET mutation.
New results show no significant associations between dietary habits and thyroid cancer risk.
Endocrinology Advisor Articles
- Fasting Glycemic Variability Indicates Increased Risk for Type 2 Diabetes
- Heritability of BMI Stronger in Obesogenic Environments
- Domestic Refrigeration May Pose Underestimated Risk for Insulin Quality
- Adverse Events Associated With Diazoxide Treatment for Congenital Hyperinsulinism
- Sitagliptin Provides Better Glycemic Control Than Dapagliflozin in T2D With Renal Impairment
- Causes of Burnout in Resident Physicians Examined
- Thyroid Hormone Therapy Not Beneficial for Subclinical Hypothyroidism
- Bone-Derived Factors in the Treatment of Diabetes
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Without Medicaid Expansion, Poor Patients Forgo Medical Care